Intentional CYP3A4 inhibition in venetoclax-based AML therapy: from incidental observation to validated clinical strategy.

Saved in:

Bibliographic Details
Title:	Intentional CYP3A4 inhibition in venetoclax-based AML therapy: from incidental observation to validated clinical strategy.
Authors:	De la Garza-Salazar, Fernando¹ (AUTHOR) fernandodelagarza@gmail.com
Source:	Leukemia & Lymphoma. Jun2026, p1-3. 3p.
Database:	Academic Search Ultimate

Description
ISSN:	10428194
DOI:	10.1080/10428194.2026.2685236